世界の医薬品ロジスティクス 市場は、2025年に116901百万米ドルと算定されており、2026年には123708百万米ドルとなる見通しです。2026年から2032年の期間においては年平均成長率（CAGR）5.5%で推移し、2032年には170768百万米ドルに達すると予測されています。

本レポートは、医薬品ロジスティクス メーカー、新規参入企業、および業界バリューチェーン全体の企業に対し、市場全体およびサブセグメント別の収益、生産量、平均価格に関する情報を、企業別、タイプ別、用途別、地域別に提供します。
世界の医薬品ロジスティクス 市場について、定量的・定性的分析を交えた包括的な概観を提供し、企業関係者が成長戦略の策定、競争環境の評価、現行市場における自社の位置付けの分析、医薬品ロジスティクス に関する情報に基づいたビジネス判断を行うことを支援します。医薬品ロジスティクス 市場の規模、推定値及び予測値の観点から提示し、2025年を基準年として、2021年から2032年までの過去データ及び予測データを収録しております。

報告対象範囲
売上高・数量予測、企業シェア、競争環境、成長要因および市場トレンド

市場セグメンテーション
企業一覧
Deutsche Post DHL
Kuehne + Nagel
UPS
McKesson
FedEx
Nippon Express
Cencora
SF Express
CMA CGM
DSV
Kerry Logistics
CH Robinson
Air Canada Cargo
Sinopharm Group
Shanghai Pharma
CR Pharma
Jointown Logistics


タイプ別
Cold Chain Logistics
Non-cold Chain Logistics


用途別
Chemical Pharma
Bio Pharma


製品カテゴリー


市場セグメント
National Distribution
Regional Distribution
Cross-border Logistics
Hospital Direct Delivery
Other

地域別
北米（アメリカ、カナダ、メキシコ）
欧州（ドイツ、フランス、イギリス、イタリアなど）
アジア太平洋（中国、日本、韓国、東南アジア、インドなど）
南米（ブラジルなど）
中東・アフリカ（トルコ、GCC諸国、アフリカなど）
本レポートは、世界の医薬品ロジスティクス 市場を包括的にセグメント化しております。地域別市場規模、タイプ別、用途別、企業別の市場規模も提供されます。より深い洞察を得るため、競争環境、主要競合他社、それぞれの市場順位をプロファイリングし、技術動向や新製品開発についても論じております。

本レポートの構成
第1章：医薬品ロジスティクス の定義および調査範囲を明確化し、市場セグメント（タイプ別、用途別など）の概要を提示します。各セグメントの市場規模と将来の成長可能性を網羅し、現在の市場状況の概要を提供するとともに、短期・中期・長期の発展トレンドを分析します
第2章：医薬品ロジスティクス メーカーの競争環境について、価格、生産量、価値ベースの市場シェア、最新の開発計画、合併・買収情報を含め詳細に分析します
第3章：医薬品ロジスティクス の生産量／生産高および価値を地域・国別に検証し、今後6年間の各地域の市場規模と成長可能性について定量的な評価を提供します
第4章：地域および国レベルでの医薬品ロジスティクス の消費動向を分析します。各地域および主要国における市場規模と成長可能性を定量化し、市場開発状況、見通し、対応可能な市場規模、国内生産量を概説します
第5章：医薬品ロジスティクス に基づくタイプ別市場セグメントの構造を整理し、各セグメントの市場規模と成長ポテンシャルを明確化することで、企業・投資家によるブルーオーシャン機会の発見を支援します
第6章：用途別に医薬品ロジスティクス の市場セグメントを整理し、各分野の市場規模、成長ポテンシャル、需要拡大余地を提示することで、下流市場における有望な参入機会や競争優位の確立に向けた判断材料を提供します
第7章：医薬品ロジスティクス の主要プレイヤーを分析し、主要企業の基本情報（製品生産量／生産高、価値、価格、粗利益率、製品ポートフォリオ／新製品導入、最近の動向）を詳細に説明します
第8章：医薬品ロジスティクス の上流および下流セグメントを含む業界バリューチェーンをレビューします
第9章：医薬品ロジスティクス 市場の動向と最新トレンドについて議論します。これには、メーカーにとっての推進要因、制約要因、課題、リスク、米国関税、関連政策分析が含まれます
第10章：主な調査結果と結論をまとめます
第11章：付録

The global Pharmaceutical Logistics market was valued at US$ 116901 million in 2025 and is anticipated to reach US$ 170768 million by 2032, at a CAGR of 5.5% from 2026 to 2032.

Pharmaceutical logistics refers to the specialized process of planning, implementing, and controlling the efficient movement, storage, and distribution of pharmaceutical products. This includes managing the supply chain to ensure that medicines, vaccines, and other healthcare products are transported under strict conditions, such as temperature-controlled environments, to maintain their quality and efficacy. It also involves adhering to regulatory standards, ensuring product safety, and providing real-time tracking to prevent counterfeiting or delays, ultimately delivering these critical products to hospitals, pharmacies, and patients safely and on time.The average gross profit margin of this product is 28%.

Population aging, the growing management of chronic diseases, and the commercialization of innovative medicines, biologics, vaccines, radiopharmaceuticals and cell and gene therapies are raising the technical requirements of pharmaceutical supply chains. High-value, temperature-sensitive and patient-specific products require integrated capabilities spanning global transportation, regional warehousing, last-mile delivery and complete quality documentation. At the same time, regulatory frameworks for third-party pharmaceutical logistics are becoming more established, while pharmaceutical distributors are accelerating digitalization, automation and cross-regional network integration. Major international logistics groups are also positioning life sciences and healthcare as strategic growth areas, shifting industry value from basic freight charges toward specialized supply chain solutions and long-term service contracts.
The principal risk in pharmaceutical logistics is that product-quality responsibility extends throughout the entire storage and transportation process. Temperature excursions, packaging failures, delayed handovers or incomplete traceability records can result in product disposal, supply disruption, regulatory penalties and reputational damage. Differences among national and regional requirements concerning pharmaceutical quality, import authorization, data retention and transport validation add further complexity to cross-border operations, which are also exposed to geopolitical uncertainty, tariffs, airfreight capacity and customs delays. Continuous investment is required in cold-storage facilities, refrigerated vehicles, validation systems, backup power and information platforms, while shortages of qualified personnel, fragmented system interfaces, customer pricing pressure and fluctuating shipment volumes place additional demands on network density, quality governance and cost control.
Downstream customers are moving away from purchasing isolated warehousing or transportation services and toward end-to-end, visible and auditable supply chain solutions. Pharmaceutical manufacturers increasingly require launch-support logistics, clinical-trial sample management, cross-border temperature-controlled transportation and inventory-risk control. Hospitals and pharmaceutical distributors are expanding hospital SPD, automated replenishment and coordinated regional distribution, while specialty pharmacies and digital-health platforms are stimulating direct-to-patient delivery of specialty drugs, chronic-disease medicines and home-treatment products. Future shipments will increasingly involve smaller batches, higher delivery frequency, multiple temperature ranges and personalized fulfillment, making real-time location monitoring, temperature alerts, predictive replenishment, electronic proof of delivery and closed-loop deviation management essential service capabilities.

This report delivers a comprehensive overview of the global Pharmaceutical Logistics market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Pharmaceutical Logistics. The Pharmaceutical Logistics market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Pharmaceutical Logistics market comprehensively. Regional market sizes by Type, by Application, by Logistics Service, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Pharmaceutical Logistics manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation
By Company
Deutsche Post DHL
Kuehne + Nagel
UPS
McKesson
FedEx
Nippon Express
Cencora
SF Express
CMA CGM
DSV
Kerry Logistics
CH Robinson
Air Canada Cargo
Sinopharm Group
Shanghai Pharma
CR Pharma
Jointown Logistics

Segment by Type
Cold Chain Logistics
Non-cold Chain Logistics

Segment by Logistics Service
Warehousing
Transportation
Last-mile Delivery
Other

Segment by Distribution Network
National Distribution
Regional Distribution
Cross-border Logistics
Hospital Direct Delivery
Other

Segment by Application
Chemical Pharma
Bio Pharma

By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA

Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Logistics Service, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Pharmaceutical Logistics companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmaceutical Logistics Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Cold Chain Logistics
1.2.3 Non-cold Chain Logistics
1.3 Market by Logistics Service
1.3.1 Global Pharmaceutical Logistics Market Size Growth Rate by Logistics Service: 2021 vs 2025 vs 2032
1.3.2 Warehousing
1.3.3 Transportation
1.3.4 Last-mile Delivery
1.3.5 Other
1.4 Market by Distribution Network
1.4.1 Global Pharmaceutical Logistics Market Size Growth Rate by Distribution Network: 2021 vs 2025 vs 2032
1.4.2 National Distribution
1.4.3 Regional Distribution
1.4.4 Cross-border Logistics
1.4.5 Hospital Direct Delivery
1.4.6 Other
1.5 Market by Application
1.5.1 Global Pharmaceutical Logistics Market Growth by Application: 2021 vs 2025 vs 2032
1.5.2 Chemical Pharma
1.5.3 Bio Pharma
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered

2 Global Growth Trends
2.1 Global Pharmaceutical Logistics Market Perspective (2021–2032)
2.2 Global Pharmaceutical Logistics Growth Trends by Region
2.2.1 Global Pharmaceutical Logistics Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Pharmaceutical Logistics Historic Market Size by Region (2021–2026)
2.2.3 Pharmaceutical Logistics Forecasted Market Size by Region (2027–2032)
2.3 Pharmaceutical Logistics Market Dynamics
2.3.1 Pharmaceutical Logistics Industry Trends
2.3.2 Pharmaceutical Logistics Market Drivers
2.3.3 Pharmaceutical Logistics Market Challenges
2.3.4 Pharmaceutical Logistics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Pharmaceutical Logistics Players by Revenue
3.1.1 Global Top Pharmaceutical Logistics Players by Revenue (2021–2026)
3.1.2 Global Pharmaceutical Logistics Revenue Market Share by Players (2021–2026)
3.2 Global Top Pharmaceutical Logistics Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Pharmaceutical Logistics Revenue
3.4 Global Pharmaceutical Logistics Market Concentration Ratio
3.4.1 Global Pharmaceutical Logistics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical Logistics Revenue in 2025
3.5 Global Key Players of Pharmaceutical Logistics Head Offices and Areas Served
3.6 Global Key Players of Pharmaceutical Logistics, Products and Applications
3.7 Global Key Players of Pharmaceutical Logistics, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans

4 Pharmaceutical Logistics Breakdown Data by Type
4.1 Global Pharmaceutical Logistics Historic Market Size by Type (2021–2026)
4.2 Global Pharmaceutical Logistics Forecasted Market Size by Type (2027–2032)

5 Pharmaceutical Logistics Breakdown Data by Application
5.1 Global Pharmaceutical Logistics Historic Market Size by Application (2021–2026)
5.2 Global Pharmaceutical Logistics Forecasted Market Size by Application (2027–2032)

6 North America
6.1 North America Pharmaceutical Logistics Market Size (2021–2032)
6.2 North America Pharmaceutical Logistics Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Pharmaceutical Logistics Market Size by Country (2021–2026)
6.4 North America Pharmaceutical Logistics Market Size by Country (2027–2032)
6.5 United States
6.6 Canada

7 Europe
7.1 Europe Pharmaceutical Logistics Market Size (2021–2032)
7.2 Europe Pharmaceutical Logistics Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Pharmaceutical Logistics Market Size by Country (2021–2026)
7.4 Europe Pharmaceutical Logistics Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland

8 Asia-Pacific
8.1 Asia-Pacific Pharmaceutical Logistics Market Size (2021–2032)
8.2 Asia-Pacific Pharmaceutical Logistics Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Pharmaceutical Logistics Market Size by Region (2021–2026)
8.4 Asia-Pacific Pharmaceutical Logistics Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand

9 Latin America
9.1 Latin America Pharmaceutical Logistics Market Size (2021–2032)
9.2 Latin America Pharmaceutical Logistics Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Pharmaceutical Logistics Market Size by Country (2021–2026)
9.4 Latin America Pharmaceutical Logistics Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Pharmaceutical Logistics Market Size (2021–2032)
10.2 Middle East & Africa Pharmaceutical Logistics Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Pharmaceutical Logistics Market Size by Country (2021–2026)
10.4 Middle East & Africa Pharmaceutical Logistics Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE

11 Key Players Profiles
11.1 Deutsche Post DHL
11.1.1 Deutsche Post DHL Company Details
11.1.2 Deutsche Post DHL Business Overview
11.1.3 Deutsche Post DHL Pharmaceutical Logistics Introduction
11.1.4 Deutsche Post DHL Revenue in Pharmaceutical Logistics Business (2021–2026)
11.1.5 Deutsche Post DHL Recent Development
11.2 Kuehne + Nagel
11.2.1 Kuehne + Nagel Company Details
11.2.2 Kuehne + Nagel Business Overview
11.2.3 Kuehne + Nagel Pharmaceutical Logistics Introduction
11.2.4 Kuehne + Nagel Revenue in Pharmaceutical Logistics Business (2021–2026)
11.2.5 Kuehne + Nagel Recent Development
11.3 UPS
11.3.1 UPS Company Details
11.3.2 UPS Business Overview
11.3.3 UPS Pharmaceutical Logistics Introduction
11.3.4 UPS Revenue in Pharmaceutical Logistics Business (2021–2026)
11.3.5 UPS Recent Development
11.4 McKesson
11.4.1 McKesson Company Details
11.4.2 McKesson Business Overview
11.4.3 McKesson Pharmaceutical Logistics Introduction
11.4.4 McKesson Revenue in Pharmaceutical Logistics Business (2021–2026)
11.4.5 McKesson Recent Development
11.5 FedEx
11.5.1 FedEx Company Details
11.5.2 FedEx Business Overview
11.5.3 FedEx Pharmaceutical Logistics Introduction
11.5.4 FedEx Revenue in Pharmaceutical Logistics Business (2021–2026)
11.5.5 FedEx Recent Development
11.6 Nippon Express
11.6.1 Nippon Express Company Details
11.6.2 Nippon Express Business Overview
11.6.3 Nippon Express Pharmaceutical Logistics Introduction
11.6.4 Nippon Express Revenue in Pharmaceutical Logistics Business (2021–2026)
11.6.5 Nippon Express Recent Development
11.7 Cencora
11.7.1 Cencora Company Details
11.7.2 Cencora Business Overview
11.7.3 Cencora Pharmaceutical Logistics Introduction
11.7.4 Cencora Revenue in Pharmaceutical Logistics Business (2021–2026)
11.7.5 Cencora Recent Development
11.8 SF Express
11.8.1 SF Express Company Details
11.8.2 SF Express Business Overview
11.8.3 SF Express Pharmaceutical Logistics Introduction
11.8.4 SF Express Revenue in Pharmaceutical Logistics Business (2021–2026)
11.8.5 SF Express Recent Development
11.9 CMA CGM
11.9.1 CMA CGM Company Details
11.9.2 CMA CGM Business Overview
11.9.3 CMA CGM Pharmaceutical Logistics Introduction
11.9.4 CMA CGM Revenue in Pharmaceutical Logistics Business (2021–2026)
11.9.5 CMA CGM Recent Development
11.10 DSV
11.10.1 DSV Company Details
11.10.2 DSV Business Overview
11.10.3 DSV Pharmaceutical Logistics Introduction
11.10.4 DSV Revenue in Pharmaceutical Logistics Business (2021–2026)
11.10.5 DSV Recent Development
11.11 Kerry Logistics
11.11.1 Kerry Logistics Company Details
11.11.2 Kerry Logistics Business Overview
11.11.3 Kerry Logistics Pharmaceutical Logistics Introduction
11.11.4 Kerry Logistics Revenue in Pharmaceutical Logistics Business (2021–2026)
11.11.5 Kerry Logistics Recent Development
11.12 CH Robinson
11.12.1 CH Robinson Company Details
11.12.2 CH Robinson Business Overview
11.12.3 CH Robinson Pharmaceutical Logistics Introduction
11.12.4 CH Robinson Revenue in Pharmaceutical Logistics Business (2021–2026)
11.12.5 CH Robinson Recent Development
11.13 Air Canada Cargo
11.13.1 Air Canada Cargo Company Details
11.13.2 Air Canada Cargo Business Overview
11.13.3 Air Canada Cargo Pharmaceutical Logistics Introduction
11.13.4 Air Canada Cargo Revenue in Pharmaceutical Logistics Business (2021–2026)
11.13.5 Air Canada Cargo Recent Development
11.14 Sinopharm Group
11.14.1 Sinopharm Group Company Details
11.14.2 Sinopharm Group Business Overview
11.14.3 Sinopharm Group Pharmaceutical Logistics Introduction
11.14.4 Sinopharm Group Revenue in Pharmaceutical Logistics Business (2021–2026)
11.14.5 Sinopharm Group Recent Development
11.15 Shanghai Pharma
11.15.1 Shanghai Pharma Company Details
11.15.2 Shanghai Pharma Business Overview
11.15.3 Shanghai Pharma Pharmaceutical Logistics Introduction
11.15.4 Shanghai Pharma Revenue in Pharmaceutical Logistics Business (2021–2026)
11.15.5 Shanghai Pharma Recent Development
11.16 CR Pharma
11.16.1 CR Pharma Company Details
11.16.2 CR Pharma Business Overview
11.16.3 CR Pharma Pharmaceutical Logistics Introduction
11.16.4 CR Pharma Revenue in Pharmaceutical Logistics Business (2021–2026)
11.16.5 CR Pharma Recent Development
11.17 Jointown Logistics
11.17.1 Jointown Logistics Company Details
11.17.2 Jointown Logistics Business Overview
11.17.3 Jointown Logistics Pharmaceutical Logistics Introduction
11.17.4 Jointown Logistics Revenue in Pharmaceutical Logistics Business (2021–2026)
11.17.5 Jointown Logistics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer